Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis

被引:7
|
作者
Wu, Haiting [1 ]
Lu, Yiyun [2 ]
Hu, Rongrong [1 ]
Ye, Wei [1 ]
Wen, Yubing [1 ]
Cai, Jianfang [1 ,3 ]
Li, Hang [1 ]
Li, Xuemei [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Div Nephrol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Internal Med, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Div Nephrol, Beijing 100037, Peoples R China
关键词
Anti-neutrophil cytoplasmic antibody associated vasculitis; Rheumatoid arthritis; Glomerulonephritis; WEGENERS-GRANULOMATOSIS; CRESCENTIC GLOMERULONEPHRITIS; MICROSCOPIC POLYANGIITIS; CLASSIFICATION; MARKER;
D O I
10.1186/s12882-022-02788-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of AAV with and without coexisting RA are similar. This observational study aimed to investigate the clinicopathological manifestations of AAV with coexisting RA and to explore potential predictors for identifying AAV superimposed on RA. Methods Patients with both AAV and RA were identified by searching our hospital database and the literature. Data including age, sex, clinical manifestation, laboratory tests, renal pathology, and therapeutic regimens were retrieved. To assess the difference in clinical features and renal pathology between AAV patients with and without RA, we conducted 1:4 matched case-control studies. Results A total of 47 patients were identified, 15 from our hospital and 32 from the literature, and 33 (70.2%) were women. AAV was diagnosed later than RA in 83.0% of the patients and manifested as microscopic polyangiitis (MPA) in 78.7% of the patients. The kidney was the most frequently involved extra-articular organ (74.5%), followed by the lung (51.1%), and skin (8.5%). Patients with both AAV and RA were more likely to be asymptomatic (26.7% vs 3.3%, p = 0.013) than those with isolated AAV. However, they did not differ in other clinicopathological features. In RA patients, those with ANCA associated glomerulonephritis, were more likely to have decreased renal function at renal biopsy as opposed to those with primary glomerulonephritis. Conclusions AAV can coexist with RA. In this coexistence, AAV usually develops after RA, is more likely to be asymptomatic, and manifests predominately as MPA with renal involvement. Thus, we should remain vigilant to superimposed AAV on RA.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] COMPLEMENT REGULATORY PROTEINS IN KIDNEYS OF PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS
    Cheng, Lu
    Gou, Shenju
    Ma, Liang
    Fu, Ping
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 141 - 141
  • [22] Rivaroxaban Induced Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
    Chopra, M.
    Cristan, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [24] Unusual histological evidence or anti-neutrophil cytoplasmic antibody associated vasculitis
    de Fremont, Gregoire Martin
    Hourseau, Murielle
    Rouger, Margaux
    Papo, Thomas
    Goulenok, Tiphaine
    [J]. RHEUMATOLOGY, 2024, 63 (06) : e160 - e161
  • [25] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Tervaert, JWC
    Stegeman, CA
    Kallenberg, CGM
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 211 - 217
  • [26] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Lee, Richard W.
    D'Cruz, David P.
    [J]. DRUGS, 2008, 68 (06) : 747 - 770
  • [27] Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Coughlan, A. M.
    Freeley, S. J.
    Robson, M. G.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (03): : 229 - 237
  • [28] NONLINEAR PHARMACOKINETICS OF RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS
    Mulleman, Denis
    Bensalem, Amina
    Ternant, David
    Paintaud, Gilles
    Cornec, Divi
    Specks, Ulrich
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 433 - 433
  • [29] Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Alberici, Federico
    Martorana, Davide
    Vaglio, Augusto
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i37 - i45
  • [30] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
    Binda, Valentina
    Favi, Evaldo
    Calatroni, Marta
    Moroni, Gabriella
    [J]. MEDICINA-LITHUANIA, 2021, 57 (12):